People · Operator
Named in public records as an officer, director or promoter · active 2019–2025 · Biotechnology, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| TripleBar Bio, Inc. | — | Biotechnology | Series B | $19.8M | $190.9M | 2023 |
| Lunair Medical, Inc. | — | Healthtech | Series A | $7.5M | $24.8M | 2025 |
| Levin Eye Care LLC | — | Healthtech | Pre-Seed | $1.0M | $34.5M | 2019 |
Howard Levin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Howard Levin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| PAUL LAVIOLETTE | 1 | 12 |
| David Friedberg | 1 | 8 |
| David Neustaedter | 1 | 7 |
| Maria Cho | 1 | 3 |
| Richard Levin | 1 | 3 |
| Mark Christopherson | 1 | 2 |
| Michael Hurley | 1 | 1 |
| Rose Wardle | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.